The best medicines for OCD are a class of antidepressants called SSRIs, which work by increasing serotonin activity in the brain. Five medications are FDA-approved specifically for OCD, and most treatment guidelines recommend starting with one of the four SSRIs: fluoxetine (Prozac), fluvoxamine (Luvox), sertraline (Zoloft), or paroxetine (Paxil). No single one is clearly superior to the others, so the “best” choice depends on your side effect tolerance, other medications you take, and whether you’ve tried any of them before.
What makes OCD medication different from treating depression is the dose. OCD typically requires higher doses and longer trials before you see results. Understanding that timeline, and what options exist if the first medication doesn’t work, is key to getting the most out of treatment.
FDA-Approved Medications for OCD
Five medications carry FDA approval for OCD. Four are SSRIs and one is an older tricyclic antidepressant called clomipramine (Anafranil). All five increase serotonin signaling in the brain, which is why they’re sometimes grouped together as “serotonin reuptake inhibitors” or SRIs.
- Fluoxetine (Prozac): 20 to 80 mg daily, approved for adults and children 7 and older
- Sertraline (Zoloft): 100 to 200 mg daily, approved for adults and children 6 and older
- Fluvoxamine (Luvox): 150 to 300 mg daily, approved for adults and children 8 and older
- Paroxetine (Paxil): 20 to 60 mg daily, approved for adults only
- Clomipramine (Anafranil): approved for adults and children 10 and older
Those dose ranges are specifically for OCD, and they’re notably higher than what’s prescribed for depression. Someone taking sertraline for depression might use 50 mg daily. For OCD, the target range starts at 100 mg and can go up to 200 mg. This higher dosing requirement is one reason OCD medications take careful, gradual adjustment.
How SSRIs Compare to Each Other
Head-to-head studies have not consistently shown one SSRI to be more effective than another for OCD. The choice often comes down to practical differences. Sertraline and fluoxetine tend to be the most commonly prescribed first because they have long track records, are available as generics, and are approved for children. Fluvoxamine is effective but interacts with more medications than the others. Paroxetine is limited to adults and carries a higher risk of weight gain and sexual side effects.
If one SSRI doesn’t work, switching to another is a standard next step. People who don’t respond to one may still respond well to a different one, even though the medications work through a similar mechanism.
What to Expect: Timeline and Response Rates
OCD medications work slowly. You’ll typically notice the first signs of improvement around six weeks, though it can take up to eight weeks before any benefit appears. A full trial requires 10 to 12 weeks at the highest dose you can comfortably tolerate. Stopping earlier makes it impossible to tell whether the medication would have worked.
When medication does work, the improvement is meaningful but usually partial. About 60% of patients see their symptoms decrease by 40% to 50% or more over a 10- to 12-week trial. That means intrusive thoughts become less frequent and less distressing, and compulsions feel easier to resist or delay. It doesn’t mean symptoms disappear entirely. Most people with OCD benefit from combining medication with a specific type of therapy called exposure and response prevention, which teaches you to tolerate obsessive thoughts without performing compulsions.
If you’re in that remaining 40% who don’t respond adequately to the first SSRI, there are well-established next steps.
When the First Medication Doesn’t Work
Clomipramine is often considered when SSRIs haven’t provided enough relief. It’s the oldest OCD medication and, in some analyses, appears slightly more effective than SSRIs. The tradeoff is a heavier side effect profile: it can cause dry mouth, constipation, drowsiness, dizziness, and weight gain, and requires heart monitoring in some cases. For this reason, most clinicians try SSRIs first and reserve clomipramine for people who need more potent serotonin activity.
Another strategy for treatment-resistant OCD is adding a low dose of an antipsychotic medication to an existing SSRI. This is called augmentation. Risperidone has the strongest evidence for this role, with multiple analyses confirming it reduces OCD symptoms when added to an SSRI that’s providing only partial relief. Aripiprazole has also shown effectiveness in controlled trials. Other antipsychotics like quetiapine and olanzapine have been studied, but the results are inconsistent, and pooled analyses have not been able to confirm they work better than a placebo for OCD specifically.
Augmentation is typically tried after at least two adequate SSRI trials have fallen short. “Adequate” means the right dose for the right amount of time, not just a few weeks at a starting dose.
Side Effects at OCD Doses
Because OCD requires higher doses than depression, side effects can be more pronounced. The most common ones are manageable for most people, but they’re worth knowing about before you start.
Sexual side effects are the most frequently reported issue, affecting up to 75% of people on higher doses. This includes reduced desire, difficulty reaching orgasm, and delayed ejaculation. Paroxetine tends to cause the most sexual dysfunction among the SSRIs.
Stomach problems like nausea, diarrhea, and abdominal discomfort are common early in treatment and with dose increases. Fluvoxamine and sertraline are the most likely to cause GI issues. These symptoms often improve after a few weeks as your body adjusts.
Weight gain is a real concern with long-term use. Paroxetine and sertraline are associated with the most significant changes, with some reports of gains up to 22 pounds over a year. Fluoxetine tends to be more weight-neutral, which is one reason it’s a popular first choice.
Less common but more serious risks at high doses include heart rhythm changes (particularly with citalopram and escitalopram, which are sometimes used off-label for OCD), serotonin syndrome from excessive serotonin buildup, and low sodium levels in older adults. These are rare but are the reason dose increases need medical supervision.
Despite the longer list of potential side effects at higher doses, research shows that the actual rate of people stopping medication because of side effects increases only modestly compared to lower doses. Most people tolerate OCD-level dosing reasonably well.
OCD Medication in Children
Three SSRIs and clomipramine are approved for pediatric OCD, each with a different minimum age. Sertraline has the youngest approval at age 6, followed by fluoxetine at 7, fluvoxamine at 8, and clomipramine at 10. Paroxetine is not approved for children.
Children typically start at a low dose that gets increased every three weeks as tolerated, with the goal of reaching at least a mid-range dose. The dose ranges for children overlap substantially with adult ranges: fluoxetine 10 to 80 mg, sertraline 25 to 200 mg, and fluvoxamine 25 to 300 mg. Treatment guidelines for children strongly emphasize combining medication with therapy, since exposure and response prevention is particularly effective in younger patients and may allow lower doses or shorter medication courses.
Medication vs. Therapy
The strongest evidence for OCD treatment supports either an SSRI, exposure and response prevention therapy, or both together. For mild to moderate OCD, therapy alone can be as effective as medication. For moderate to severe OCD, the combination tends to produce the best outcomes. Medication can reduce symptoms enough to make the therapy more tolerable, since confronting obsessive fears is inherently uncomfortable.
One practical advantage of medication is accessibility. A trained OCD therapist can be hard to find in many areas, while a primary care doctor or psychiatrist can prescribe an SSRI. For many people, starting medication while searching for a therapist is a reasonable approach. Medication also helps maintain gains after therapy ends, which is why many people stay on their SSRI for a year or longer after reaching a stable improvement.